French otorhinolaryngologists, actors for sustainable development
Nicolas Leboulanger(Hôpital Necker-Enfants Malades), B. Gardini(Clinique Pasteur), N. Clerc(Centre National de la Recherche Scientifique), Philippe Lesnik(Inserm), Y. Camhi(Fondation Ophtalmologique Adolphe de Rothschild), Mathieu Veyrat(Fondation Ophtalmologique Adolphe de Rothschild), O. Mazzaschi(Inserm)
European Annals of Otorhinolaryngology Head and Neck Diseases
June 17, 2023
Cited by 0
Related Papers
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
|European Heart Journal|2011|1.2k
The eROSITA X-ray telescope on SRG
|Springer Link (Chiba Institute of Technology)|2021|666
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130